+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Host defense and survival in patients with lung carcinoma



Host defense and survival in patients with lung carcinoma



Cancer 89(10): 2038-2045



Numerous studies have investigated locoregional immune responses and long term survival in patients with various types of cancer; few have focused on patients with lung carcinoma. The current study was designed to assess the prognostic value of immunomorphologic changes in locoregional lymph nodes and lymphocytic infiltration of primary tumor (LI) in patients who undergo resection for bronchogenic carcinoma. In a retrospective analysis, immune responses in locoregional lymph nodes and at primary tumor sites were studied histologically in 172 selected patients. Lymph node morphology was studied according to the system of Cottier et al. Sinus histiocytosis and paracortical lymphoid cell hyperplasia were considered to be cellular immune responses, and follicular hyperplasia of the cortical area was considered to be a humoral reaction. LI was classified with Black's method. The survival rate was estimated by using the Kaplan-Meier product-limit method. The log rank test and the Cox proportional-hazards model were used to determine statistical significance in univariate and multivariate survival analyses. Among the 172 patients, 35.5% had no evident response in regional lymph nodes, 19.8% had a marked cellular response, 11% had a marked humoral response, and 33.7% had a mixed cellular and humoral response. LI was intense in 36.6% of patients and was absent or scarcely evident in 63.4%. A lymph node cellular response and marked LI improved long term survival rates even in patients with regional lymph node metastases. Multivariate analysis identified two independent variables that had high prognostic value: lymph node immunoreactivity and LI. Lymph node immunoreactivity and LI significantly influence long term survival after curative surgery for patients with carcinoma of the lung and may be useful in stratifying patients for prospective trials of adjuvant treatment, including immunotherapy.

(PDF emailed within 1 workday: $29.90)

Accession: 046274769

Download citation: RISBibTeXText

PMID: 11066043


Related references

Influence of tumor defense of host tissue on survival of resected lung carcinoma patients. Journal of Cancer Research & Clinical Oncology 111(SUPPL): S63, 1986

Host defense and survival in patients with lung carcinoma: Prognostic significance of immunomorphologic changes in regional lymph nodes and lymphocytic infiltration of primary tumor. Cancer 89(10): 2038-2045, November 10, 2000

Influence of tumor defence of host tissue on survival of resected lung carcinoma patients. Journal of Cancer Research and Clinical Oncology 111(1 Supplement): S63-0, 1986

M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes. Journal of Immunology 196(12): 5047-5055, 2017

Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Research 58(22): 5206-5215, 1998

Host defense against opportunist microorganisms following trauma. I. Studies to determine the association between changes in humoral components of host defense and septicemia in burned patients. Annals of Surgery 188(1): 93-101, 1978

Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. Journal of Cystic Fibrosis 5(1): 17-25, 2005

IL-17 increases lung immunity and help lung host defense against K Pneumoniae infection. Journal of Investigative Medicine 47(2): 135A, 1999

Innate host defense of the lung: effects of lung-lining fluid pH. Lung 182(5): 297-317, 2005

Intrinsic and innate defenses in the lung: intersection of pathways regulating lung morphogenesis, host defense, and repair. Journal of Clinical Investigation 109(5): 565-569, 2002

Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers in Surgery and Medicine 39(5): 394-402, 2007

Evaluation of the long term survival of patients with small cell carcinoma of the lung beyond their median survival time in relation to therapeutic modalities and stages of the tumor. International Journal of Radiation Oncology, Biology, Physics 8(SUPPL 1): 70, 1982

Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system. Cancer 98(5): 894-899, 2003

Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. American Review of Respiratory Disease 137(6): 1268-1274, 1988

Optimism and survival in lung carcinoma patients. Cancer 100(6): 1276-1282, 2004